ALGS vs TDG · rev $2.8M vs P/E 41, rev $8.83B
Aligos Therapeutics Inc (ALGS) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported ALGS revenue for 2026-06-30 was $2.8M. Net income was -$24.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALGS currently screens at market cap $44.1M.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
ALGS currently screens at market cap $44.1M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the ALGS and TDG stock pages for the full models.
Not investment advice.